A A A A
 
Pages
Meet The Team How-Tos Our Supporters How to Participate in Precision Panc Membership Meeting Minutes Remit of Steering Committee Patient Stories Documents Working with the NHS Patient Public Engagement Meetings Governance News Clinicians Area Clinical Trials What is precision medicine? Information and Support What is Pancreatic Cancer? Current Research Our Researchers Privacy Policy Patients and Carers Contact Us About us Home
Posts
Precision-Panc Recruits Patient 250 Marking World Pancreatic Cancer Day Precision-Panc working with myTomorrows Precision-Panc Roundtable Final Report New Glasgow Cancer Assays by GPOL and Agilent Technologies Precision-Panc opens site 25! Precision-Panc Summer Newsletter Precision-Panc Recruits Patient 200! Precision-Panc Brochure Royal Bournemouth Hospital Opens Finding the right treatment for the patient CRUK animate the Precision-Panc platform CRUK / Precision-Panc Video Professor Biankin receives the Order of Australia in Queen’s Birthday Honours Precision-Panc opens its 20th Site Precision Panc Spring Newsletter Precision-Panc Opens Site 19 Recent Media Pieces Regarding 100 Patient Milestone Site 17 opens for Precision-Panc PRIMUS 002 opens Informing the Future of Genomic Medicine in Scotland Report is Published St James’s University Hospital Opens Precision-Panc Opens its 15th site Glasgow Experts Lead UK Pancreatic Cancer Research 11th site opens to PRECISION-Panc Scotsman Conferences Blogspot November is Pancreatic Cancer Awareness Month First Precision-Panc Trial Opens In Glasgow Cancer Research UK Investment Landscape of pancreatic neuroendocrine cancer Whole Genome Sequencing from EUS biopsies Upcoming Pancreas 2016 Conference Scottish Genome Partnership Announced Identification of four Pancreatic Cancer subtypes offers new treatment insight into the disease First Minister announces £4m ‘Precision Medicine Ecosystem’
Menu
 
 
Home | Team Members | Derek Grose
 


Department:
Clinical lead for PRIMUS 002

Institution:
Beatson West of Scotland Cancer Centre

Derek Grose

Chief Investigator of PRIMUS 002

‌Derek is a Consultant Clinical Oncologist + Honorary Senior Lecturer at the Beatson West of Scotland Cancer Centre since Jan 2011 with sub speciality interests in Upper GI and Head/Neck. His main research interests are in technical radiotherapy in Upper GI malignancy and systemic therapy trials in Head/Neck cancers.

He has a number of current research grants including the development of autosegmentation software to aid target definition in radiotherapy planning in MRI and a recently awarded Pancreatic Cancer UK (PCUK) grant to explore the correlation of hypoxic imaging, using PET Fluromisonidazole (F-MISO), with pathological specimens in patients undergoing neoadjuvant (chemo) radiotherapy for borderline resectable pancreatic cancer.
He is the Clinical Chief Investigator for the PRIMUS 002 trial focusing on biomarker and liquid biopsy development in the neoadjuvant setting in Pancreatic Cancer.

© 2019 Precision Panc
Web design by Creatomatic
This site uses cookies.
Configure
 
Read our privacy policy

This site uses cookies for marketing, personalisation, and analysis purposes. You can opt out of this at any time or view our full privacy policy for more information.